GLP-1 Agonists are a class of medications used primarily to treat type 2 diabetes. They mimic the action of the glucagon-like peptide-1 hormone, which helps regulate blood sugar levels. By stimulating insulin secretion and reducing glucagon release, these drugs help lower blood sugar after meals. In addition to managing blood sugar, GLP-1 Agonists can promote weight loss by reducing appetite and slowing gastric emptying. Common examples include liraglutide and semaglutide. These medications are typically administered via injection and are often prescribed alongside lifestyle changes for better diabetes management.